Company / Operating Margin
NEKTAR THERAPEUTICS Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-253.7%
FY2025
5-year range
-437.8% / -253.7%
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#102 of 135
Health Care
What the data says
NEKTAR THERAPEUTICS's operating margin of -253.7% is lower than 76% of companies in the Health Care sector (FY2025). Operating Margin has fluctuated over the past 10 years, ranging from -437.8% in FY2023 to 57.6% in FY2020.
Based on SEC 10-K filings.
-253.7% in FY2025 with a 5-year CAGR of -311.3%.
Improved from -437.8% to -253.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +155.0pp
- 5-Year Change
- -311.3pp
- 10-Year Change
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 135This company -253.7% Sector average -774.4%
▼
+67.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 13.3% year-over-year.
- Currently 520.8pp above the Health Care sector average.
- Peak operating margin was recorded in FY2020.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -253.7% | +13.3% |
| FY2024 | -292.6% | +33.2% |
| FY2023 | -437.8% | -7.1% |
| FY2022 | -408.6% | +6.7% |
| FY2021 | -437.8% | -859.3% |
| FY2020 | 57.6% | +397.5% |
| FY2019 | -19.4% | +71.6% |
| FY2018 | -68.2% | +71.7% |
| FY2017 | -241.2% | -2837.8% |
| FY2016 | -8.2% | +35.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026